Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Please see the latest updates concerning our response to coronavirus.

AI could predict risk of lung cancer coming back

Computer scientists working with pathologists have trained an AI tool to determine which patients with lung cancer have a higher risk of their disease coming back after treatment.
Read more
Pressing a post-coronavirus reset button on cancer research

The global COVID-19 pandemic has ground the world as we know it to a halt – and cancer research is no exception. ICR researcher Professor Udai Banerji reflects on this opportunity to take stock of the challenges faced in cancer research, and restart with ambitious new plans.
Read more
Approval of olaparib offers men first gene-targeted medicine for prostate cancer

The ICR has strongly welcomed the approval by the US FDA of the genetically targeted drug olaparib for some men with advanced prostate cancer.
Read more
Let’s finish it: Centre for Cancer Drug Discovery Appeal

We are creating a new state-of-the art drug discovery centre to create more and better drugs for cancer patients. The centre is a £75m build – and we now have less than £2m to raise. To make our building a reality, we urgently need your philanthropic support.
Support us
Thousands of lives could be lost to delays in cancer surgery during COVID-19 pandemic

Delays to cancer surgery and other treatment caused by the coronavirus crisis could result in thousands of additional deaths linked to the pandemic in England, a major new study reports.
Read more

1/5

Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Find out more
Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Find out more
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Find out more
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Find out more
Making it count

We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
Find out more
Winner of Queen's Anniversary Prize

The ICR has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Read more